Basic Information
LncRNA/CircRNA Name | HOTAIRM1 |
Synonyms | NA |
Region | GRCh38_7:27095647-27100265 |
Ensemble | ENSG00000233429 |
Refseq | NR_038366 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | papillary thyroid cancer |
ICD-0-3 | NA |
Methods | qPCR, Luciferase reporter assay etc |
Sample | PTC tissues and adjacent normal tissues ,cell lines (Nthy-ori 3-1, NPA87, CGTHW-1, K1, B-CPAP, and TPC-1) |
Expression Pattern | down-regulated |
Function Description | HOTAIRM1 was significantly downregulated in tumor tissues.The results of qRT-PCR and western blotting assays suggested that HOTAIRM1 could regulate the expression of TDG in an miR-107-meditated manner. In conclusion, we validated HOTAIRM1 as a novel tumor-suppressor lncRNA in PTC and proposed that the HOTAIRM1/miR-107/TDG axis may serve as a therapeutic target for PTC. |
Pubmed ID | 32269214 |
Year | 2020 |
Title | The HOTAIRM1/miR-107/TDG axis regulates papillary thyroid cancer cell proliferation and invasion |
External Links
Links for HOTAIRM1 | GenBank HGNC NONCODE |
Links for papillary thyroid cancer | OMIM COSMIC |